8-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one

Catalog No. :
ACKSCR756
CAS No. :
1203499-36-8
Molecular Formula :
C15H13IN2O3
Molecular Weight :
396.18

IUPAC Name:8-iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one

8-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$527.00Login to see priceInquiryInquiry
1g95%$1054.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
IUPAC Name8-iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
MDL No.I166446
Molecular FormulaC15H13IN2O3
Molecular Weight396.18
SMILESO=C1N(CC2=CC=C(OC)C=C2)C3=C(I)C=CN=C3OC1
InChI KeyHHASLJWLUTWBFA-UHFFFAOYSA-N
Synonym8-Iodo-1-[(4-methoxyphenyl)methyl]-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one | 1203499-36-8 | CS-0081713 | 8-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one, AldrichCPR | MFCD13176669 | 8-iodo-1-[(4-methoxyphenyl)methyl]pyrido[2,3-b][1,4]oxazin
CAS No.1203499-36-8
PubChem CID46737982

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACKSCR756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKSCR756 route product structure diagram
    ACKSCR7561203499-36-8
Inquiry

2. ACKSCR756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKSCR756 route product structure diagram
    ACKSCR7561203499-36-8
Inquiry

Comments (0)